All these tools Exscientia , Tempus , SelfDecode offer flexible pricing models suitable for clinical geneticist, oncologist seeking AI-powered solutions to enhance their Precision Medicine Tools efforts.
Exscientia
Tempus
SelfDecode
These AI tools are among the best Precision Medicine Tools tools available in 2025. For clinical geneticist, oncologist, tools like Exscientia , Tempus , SelfDecode help streamline the Precision Medicine Tools process by offering AI-powered features.
What is Exscientia?
Exscientia, founded in 2012 in Oxford, UK, is a trailblazing AI-driven drug discovery platform for precision medicine that leverages artificial intelligence to revolutionize pharmaceutical development. Acquired by Recursion Pharmaceuticals in November 2024, Exscientia combines AI, automation, and patient-centric data to design safer, more effective drugs faster. With over $450 million in milestone payments and a pipeline of more than 10 clinical and preclinical programs, patient-first AI for drug development has delivered the first three AI-designed drugs to clinical trials, achieving 10 times productivity gains. Trusted by partners like Sanofi and Bristol Myers Squibb, Exscientia operates globally, focusing on oncology and beyond.
What is Tempus?
Tempus is a pioneering health technology company specializing in AI-enabled precision medicine, founded in 2015 by Eric Lefkofsky. It leverages artificial intelligence (AI) and big data to transform healthcare by building the world’s largest library of clinical and molecular data, exceeding 300 petabytes. This data powers personalized treatment options, primarily in oncology, but also extends to cardiology, neurology, psychiatry, radiology, and infectious diseases.
What is SelfDecode?
SelfDecode offers AI-powered DNA health reports and personalized wellness plans. Analyze your genetic data to receive tailored diet, supplement, and lifestyle recommendations.
-
Accuracy and Reliability:
4.7
-
Cost-Efficiency:
4.5
-
Customization and Flexibility:
4.8
-
Data Privacy and Security:
4.6
-
Ease of Use:
4.5
-
Functionality and Features:
4.4
-
Integration Capabilities:
4.3
-
Performance and Speed:
4.2
-
Support and Resources:
4.7
-
No ratings found!
-
Accuracy and Reliability:
4.8
-
Cost-Efficiency:
4.7
-
Customization and Flexibility:
4.9
-
Data Privacy and Security:
4.8
-
Ease of Use:
4.6
-
Functionality and Features:
4.9
-
Integration Capabilities:
4.7
-
Performance and Speed:
4.5
-
Support and Resources:
4.4
Exscientia
10x faster drug discovery.
95% accurate drug response predictions.
30% cost reduction in R&D.
Scalable AWS-powered platform.
Strong partnerships with Sanofi and Merck.
Requires technical expertise.
Minor third-party data privacy risks.
High initial costs for small firms.
Occasional support delays.
- Exscientia
- Oxford, UK
- Tempus
- Chicago
- Help Scout
- Boston